Skip to main content
Premium Trial:

Request an Annual Quote

More Sequences Needed

Despite quickly sequencing the SARS-CoV-2 when it first emerged, Quanta magazine writes that the world is not sequencing enough additional COVID-19 samples.

In December, it notes that Tedros Adhanom Ghebreyesus, the director-general of the World Health Organization, said countries needed to step up their sequencing efforts, and that the European Union called on its members to sequence at least 5 percent of their COVID-19-positive samples and the US Centers for Disease Control and Prevention likewise set a goal of sequencing 5 percent of positive cases. But, according to Quanta, most countries are falling short. For instance, it notes that the US has sequenced less than 2 percent of its cases, while Brazil and India have sequenced 0.1 percent of their cases.

By falling behind, Quanta says officials might not be able to spot new variants early. "The more large gaps in our knowledge of the variants circulating globally, the more likely we are to miss the evolution of an important variant and find ourselves taking backward steps in the fight to control the pandemic," Justin O'Grady, the former deputy director of the COVID-19 Genomics UK Consortium and new senior director of translational applications at Oxford Nanopore, tells it.

Quanta adds that the US, India, and several countries in Africa are working to bolster their sequencing efforts.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.